Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

CJ Winstein, J Stein, R Arena, B Bates, LR Cherney… - Stroke, 2016 - Am Heart Assoc
Purpose—The aim of this guideline is to provide a synopsis of best clinical practices in the
rehabilitative care of adults recovering from stroke. Methods—Writing group members were …

[PDF][PDF] Rehabilitation procedures in the management of spasticity

N Smania, A Picelli, D Munari, C Geroin… - Eur J Phys Rehabil …, 2010 - researchgate.net
MINERVA MEDICA COPYRIGHT® Page 1 Vol. 46 - No. 3 EUROPEAN JOURNAL OF PHYSICAL
AND REHABILITATION MEDICINE 423 Rehabilitation procedures in the management of …

Botulinum toxins: mechanisms of action, antinociception and clinical applications

A Wheeler, HS Smith - Toxicology, 2013 - Elsevier
Botulinum toxin (BoNT) is a potent neurotoxin that is produced by the gram-positive, spore-
forming, anaerobic bacterium, Clostridum botulinum. There are 7 known immunologically …

Effectiveness of botulinum toxin treatment for upper limb spasticity poststroke over different ICF domains: a systematic review and meta-analysis

A Andringa, I van de Port, E van Wegen, J Ket… - Archives of physical …, 2019 - Elsevier
Objective To provide a comprehensive overview of reported effects and scientific robustness
of botulinum toxin (BoNT) treatment regarding the main clinical goals related to poststroke …

[HTML][HTML] Painful hemiplegic shoulder in stroke patients: causes and management

M Murie-Fernández, MC Iragui, V Gnanakumar… - Neurología (English …, 2012 - Elsevier
Introduction The hemiplegic shoulder pain is common after a stroke. Its appearance brings
pain and limits daily living activities as well as participation in specific Neuro-rehabilitation …

[HTML][HTML] A systematic review and meta-analysis of efficacy of botulinum toxin A for neuropathic pain

A Datta Gupta, S Edwards, J Smith, J Snow… - Toxins, 2022 - mdpi.com
We performed a systematic review and meta-analysis of randomised controlled trials (RCTs)
conducted from January 2005 to June 2021 to update the evidence of Botulinum toxin A …

[HTML][HTML] Botulinum toxin for central neuropathic pain

J Park, ME Chung - Toxins, 2018 - mdpi.com
Botulinum toxin (BTX) is widely used to treat muscle spasticity by acting on motor neurons.
Recently, studies of the effects of BTX on sensory nerves have been reported and several …

Central neuropathic pain syndromes: current and emerging pharmacological strategies

KN Gurba, R Chaudhry, S Haroutounian - CNS drugs, 2022 - Springer
Central neuropathic pain is caused by a disease or lesion of the brain or spinal cord. It is
difficult to predict which patients will develop central pain syndromes after a central nervous …

Managing spasticity with drugs.

O Simon, AP Yelnik - European journal of physical and rehabilitation …, 2010 - europepmc.org
Spasticity is a common symptom observed after pyramidal system lesion. The treatment of
spasticity has considerably changed during last years, notably with the generalization of …

Poststroke hypertonicity: upper limb assessment and treatment

C Marciniak - Topics in stroke rehabilitation, 2011 - Taylor & Francis
Hypertonicity is common in patients with upper limb dysfunction following hemiplegic stroke
and is associated with greater impairment, worse function, and lower health-related quality …